Associated Papers
Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients.
Stelmach P et al.
Haematologica, 2023
37381752 (PubMed )
Supplement: 2023_282992_STELMACH_SUPPL.pdf
Compartment-specific mutational landscape of clonal hematopoiesis.
Hartmann L et al.
Leukemia, 2022
36131041 (PubMed )
Supplement: 41375_2022_1700_MOESM1_ESM.pdf
The longitudinal dynamics and natural history of clonal haematopoiesis.
Fabre MA et al.
Nature, 2022
35650444 (PubMed )
Supplement: 41586_2022_4785_MOESM11_ESM.xlsx › historical_growth
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.
Secardin L et al.
Hemasphere, 2021
34131633 (PubMed )
Supplement: hs9-5-e593-s001.pdf
TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan.
Shaikh ARK et al.
Peerj, 2021
Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcome.
Wiseman DH et al.
Ebiomedicine, 2020
32763828 (PubMed )
Supplement: mmc2.xlsx › Sheet1
TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells.
Secardin L et al.
Stem Cell Research, 2020
Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome.
Albitar F et al.
Genetic Testing and Molecular Biomarkers, 2016
Select a paper to view details